AstraZeneca
A Study Monitor at AstraZeneca's Safety Sciences China group supports the design, conduct, and reporting of non-clinical in vivo toxicology studies at Contract Research Organisations (CROs). The role involves collaborating with global colleagues and internal stakeholders to ensure high-quality toxicological data is delivered for clinical studies and regulatory submissions. This position requires an experienced in vivo toxicologist to oversee study execution and provide expert scientific input across various therapeutic areas and modalities.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
32% below the average for this role
Study Monitor - level D or E
ICON plc
Manager – In Vivo Toxicology (Home-Based, UK)
ICON plc
Associate Director, Study Operations Manager - Nonclinical Toxicology
Centessa Pharmaceuticals
Senior Scientist, Study Toxicologist
Insmed Incorporated
Vice President, Preclinical & Clinical Development
Scripps Research
Principal Scientist, Regulatory Toxicology
CSL